If you find this podcast useful please give it a rating and review on iTunes by clicking here
Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app
On today's Vox Markets Podcast:
Strategic Minerals (SML)
Peter Wale, Executive Director of Strategic Minerals (SML) discusses the exceptional assay results at their Redmoor Tin/Tungsten project in Cornwall.
Strategic Minerals Plc is an AIM-quoted, operating minerals company actively developing projects prospective for battery materials. It has an operation in the United States of America and development projects in the UK and Australia. The Company is focused on utilising its operating cash flows, along with capital raisings, to develop high quality projects aimed at supplying the metals and minerals being sought in the burgeoning electric vehicle/battery market.
(Interview starts at 1 minute 33 seconds)
To receive news about Strategic Minerals (SML) add them to your watchlist here
Cora Gold (CORA)
Dr Jonathan Forster, Chief Executive Officer of Cora Gold (CORA) gives an update on their final batch of assay results from the Tekeledougou Project in Southern Mali.
Cora Gold is a new gold exploration company focused on two world class gold regions in Mali and Senegal in West Africa. Historical exploration has resulted in the highly prospective Sanankoro Gold Discovery, in addition to multiple, high potential, drill ready gold targets within its broader portfolio. Cora Gold's primary focus is on further developing Sanankoro in the Yanfolila Gold Belt (South Mali), which Cora Gold believes has the potential for a standalone mine development. Cora Gold's highly experienced and successful management team has a proven track record in making multi-million ounce gold discoveries which have been developed into profitable mines.
(Interview starts at 17 minutes 15 seconds)
To receive news about Cora Gold (CORA) add them to your watchlist here
ImmuPharma (IMM)
Tim McCarthy Chairman of ImmuPharma (IMM) provides a general update on their progress with Lupuzor™ and their other products.
ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor™ is the company’s most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now completed dosing Lupus patients in its Phase III pivotal trial. This is only part of our story as our scientists and researchers are developing drugs to make life changing difference to peoples lives worldwide.
(Interview starts at 31 minutes 20 seconds)
To receive news about Immupharma (IMM) add them to your watchlist here
Keras Resources (KRS)
Russell Lamming, Chief Executive Officer of Keras Resources (KRS) talks about the new outcropping mineralisation Discovered at their Nayega Manganese Project in Togo.
Keras Resources currently holds a 458.375m shares in Calidus Resources (ASX), an ASX listed company which is exploring and developing a significant gold belt in Western Australia. They also hold an 85% interest in the Nayega manganese project in northern Togo and the Kamina Project which comprises of five separate exploration licences, which includes previously delineated cobalt ('Co') and nickel ('Ni') mineralisation.
(Interview starts at 49 minutes 27 seconds)
To receive news about Keras Resources (KRS) add them to your watchlist here
Click here to see the Top 5 Most Followed companies on Vox Markets
Click here to see the Top 5 Most Popular RNS on Vox Markets
